Related Experiment Video

Updated: Jun 20, 2025

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
03:42

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF

Published on: March 29, 2024

1.5K

SGLT2 Inhibitors Act Independently of SGLT2 to Confer Benefit for HFrEF in Mice

Justin H Berger1,2, Timothy R Matsuura2, Caitlyn E Bowman2,3

  • 1Division of Cardiology, Cardiovascular Institute, Children's Hospital of Philadelphia, Philadelphia, PA (J.H.B., D.P.K.).

Circulation Research
|July 23, 2024
PubMed
Abstract

No abstract available in PubMed .

Keywords:
drug therapyexperimental animal modelsheart failure, systolicketosisventricular remodeling

More Related Videos

Highly Sensitive Measurement of Glomerular Permeability in Mice with Fluorescein Isothiocyanate-polysucrose 7009:16

Highly Sensitive Measurement of Glomerular Permeability in Mice with Fluorescein Isothiocyanate-polysucrose 70

Published on: August 9, 2019

6.9K
Assessing Murine Resistance Artery Function Using Pressure Myography07:25

Assessing Murine Resistance Artery Function Using Pressure Myography

Published on: June 7, 2013

22.1K

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
414